Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer From the Danish "MALOVA" Ovarian Cancer Study

Estrid V.S. Høgdall, Lise Christensen, Susanne K. Kjaer, Jan Blaakaer, Ib Jarle Christensen, Simon Gayther, Ian J. Jacobs, Claus K. Høgdall

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Objectives.: To determine the WT1 expression level in tumor tissues from 774 women with an epithelial ovarian tumor. Secondly, to evaluate whether WT1 tissue expression levels correlate with clinico-pathological parameters and finally to investigate the prognostic value of WT1 expression levels in ovarian cancer (OC) patients. Methods.: Using tissue array we analyzed the WT1 expression level in tissues from 186 women with Low Malignant Potential tumors (LMP) (160 stage I, 5 stage II and 21 stage III) and 560 OC patients (160 stage I, 60 stage II, 289 stage III and 51 stage IV). Results.: Using 10% as cut-off level for WT1 overexpression an overall of 19% LMPs and 17% carcinomas, respectively, were found positive. For both, a higher proportion of positive tumors was found in the serous subtype compared to other histological subtypes (p < 0.0001). Kaplan-Meier survival analysis stratified by FIGO stage performed on cases using a 10% cut-off showed a shorter disease specific survival in patients with a positive WT1 expression in the tumor tissue. In a Cox survival analysis including 559 stage I to IV OC prognostic factors included FIGO stage (II vs. I: HR = 2.74, 95% CI: 1.42-5.29; III vs. II: HR = 2.23, 95% CI: 1.49-3.36; IV vs. III: HR = 1.75, 95% CI: 1.25-2.44), residual tumor after primary surgery (HR = 2.82, 95% CI: 1.87-4.26), age at diagnosis (HR = 1.02, 95% CI: 1.01-1.03), histological grade 3 of tumor versus grade 1 (grade 2 vs. grade 1: HR = 1.31, 95% CI: 0.95-1.81; grade 3 vs. grade 1: HR = 1.51, 95% CI: 1.08-2.09) and other histological tumor types vs. serous (mucinous vs. serous: HR = 0.91, 95% CI: 0.53-1.56; endometrioid vs. serous: HR = 1.02, 95% CI: 0.69-1.50; other histological types vs. serous: HR = 1.40, 95% CI: 1.01-1.95). WT1 expression (HR = 1.22, 95% CI: 0.94-1.59) had statistically no significant independent impact on survival. Conclusion.: In conclusion, based on our analyses we found that WT1 expression in clinical settings may be of limited prognostic value in Danish OC patients.

Original languageEnglish (US)
Pages (from-to)318-324
Number of pages7
JournalGynecologic Oncology
Volume106
Issue number2
DOIs
StatePublished - Aug 2007
Externally publishedYes

Keywords

  • Immunohistochemistry
  • Ovarian cancer
  • Prognosis
  • Tissue array
  • Wilms tumor gene

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer From the Danish "MALOVA" Ovarian Cancer Study'. Together they form a unique fingerprint.

Cite this